UBS Group Forecasts Strong Price Appreciation for Nutrien (NYSE:NTR) Stock

Nutrien (NYSE:NTRGet Free Report) had its target price increased by stock analysts at UBS Group from $51.00 to $53.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. UBS Group’s price target indicates a potential downside of 0.07% from the stock’s previous close.

Other analysts also recently issued research reports about the stock. Piper Sandler lifted their target price on shares of Nutrien from $58.00 to $63.00 and gave the company an “overweight” rating in a report on Monday. CIBC reaffirmed an “outperformer” rating and issued a $55.00 price objective (down from $60.00) on shares of Nutrien in a research note on Tuesday, December 10th. TD Securities decreased their target price on Nutrien from $63.00 to $61.00 and set a “buy” rating on the stock in a research note on Tuesday, November 12th. Wells Fargo & Company lifted their target price on Nutrien from $52.00 to $53.00 and gave the company an “equal weight” rating in a research report on Tuesday. Finally, Oppenheimer started coverage on shares of Nutrien in a research report on Thursday, December 12th. They set an “outperform” rating and a $60.00 price target on the stock. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and ten have given a buy rating to the stock. According to MarketBeat, Nutrien has an average rating of “Moderate Buy” and an average target price of $58.94.

Read Our Latest Stock Report on Nutrien

Nutrien Price Performance

Shares of NTR stock opened at $53.04 on Tuesday. The firm’s 50-day moving average is $47.88 and its two-hundred day moving average is $48.02. Nutrien has a 12 month low of $43.69 and a 12 month high of $60.87. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82. The company has a market capitalization of $26.05 billion, a PE ratio of 35.60, a price-to-earnings-growth ratio of 1.17 and a beta of 0.81.

Nutrien (NYSE:NTRGet Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $0.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.04). Nutrien had a return on equity of 6.99% and a net margin of 2.79%. The business had revenue of $5.35 billion for the quarter, compared to analyst estimates of $5.26 billion. During the same period in the previous year, the business posted $0.35 earnings per share. The firm’s revenue for the quarter was down 5.0% compared to the same quarter last year. Analysts predict that Nutrien will post 3.5 earnings per share for the current year.

Institutional Investors Weigh In On Nutrien

A number of large investors have recently bought and sold shares of NTR. Central Pacific Bank Trust Division acquired a new position in Nutrien in the 3rd quarter valued at about $28,000. HHM Wealth Advisors LLC raised its position in shares of Nutrien by 331.0% in the fourth quarter. HHM Wealth Advisors LLC now owns 625 shares of the company’s stock valued at $28,000 after buying an additional 480 shares during the last quarter. Exchange Traded Concepts LLC lifted its stake in shares of Nutrien by 96.7% during the fourth quarter. Exchange Traded Concepts LLC now owns 846 shares of the company’s stock valued at $38,000 after buying an additional 416 shares during the period. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Nutrien during the second quarter worth approximately $52,000. Finally, Union Bancaire Privee UBP SA purchased a new stake in Nutrien in the 4th quarter worth approximately $67,000. Institutional investors and hedge funds own 63.10% of the company’s stock.

About Nutrien

(Get Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

See Also

Analyst Recommendations for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.